We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Sponge on a String Could Replace Endoscopy

By LabMedica International staff writers
Posted on 24 Nov 2014
A sponge on a string that is easily swallowed could replace traditional endoscopy as an equally effective but less invasive way of diagnosing a condition that can be a forerunner of esophageal cancer.

Barrett's esophagus is usually diagnosed by having a biopsy during an endoscopy but this can be uncomfortable and carries some risks and it is not always practical for everyone who has symptoms like reflux and heartburn. More...


Scientists based at the Medical Research Council Cancer Unit (University of Cambridge, UK) invited more than 600 patients with Barrett's esophagus, a condition that can sometimes lead to esophageal cancer, to swallow the sponge and to undergo an endoscopy. Approximately 500 more people with symptoms like reflux and persistent heartburn did the same tests.

Over time people with these symptoms may develop changes in the cells that line the esophagus. These cells can become cancerous and so patients with Barrett's Esophagus are tested every couple of years.

The scientists found that the Cytosponge proved to be a very accurate way of diagnosing Barrett's esophagus. More than 94% of people swallowed the sponge and reported no serious side effects. Patients who were not sedated for endoscopy were more likely to rate the Cytosponge as a preferable experience. Esophageal cancer is the thirteenth most common cancer in the UK. Around 5,600 men develop the disease each year compared with 2,750 women. And each year around 5,200 men and 2,460 women die from the disease.

Rebecca Fitzgerald, MD, a professor and lead author of study said, “The Cytosponge test is safe, acceptable and has very good accuracy for diagnosing Barrett's esophagus. It should be considered as an alternative to endoscopy for diagnosing the condition and could possibly be used as a screening test in primary care. Julie Sharp, PhD, head of health information for Cancer Research UK, (London, UK) added, “These results are very encouraging and it will be good news if such a simple and cheap test can replace endoscopy for Barrett's esophagus. Death rates are unacceptably high in esophageal cancer so early diagnosis is vital.” The study was presented on November 4, 2014, at the National Cancer Research Institute's annual conference held in Liverpool (UK).

Related Links:

Medical Research Council Cancer Unit 
Cancer Research UK 



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Steam Sterilizer
Hi Vac II Line
New
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.